发明名称 |
Raltegravir salts and crystalline forms thereof |
摘要 |
The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium. |
申请公布号 |
US8722722(B2) |
申请公布日期 |
2014.05.13 |
申请号 |
US201213708141 |
申请日期 |
2012.12.07 |
申请人 |
TEVA PHARMACEUTICALS USA, INC.;TEVA PHARMACEUTICAL INDUSTRIES LTD |
发明人 |
KWOKAL ANA;HEDVATI LILACH;BURSTEIN REVITAL;YEORI ADI;MOSHKOVITS-KAPTSAN RINAT |
分类号 |
A01N43/48;A01N43/42;A01N43/54;A61K31/40;A61K31/47;A61K31/505 |
主分类号 |
A01N43/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|